Qiu M, et al. suggested that microRNA-429 (miR-429), a modulator of epithelial-to-mesenchymal transition, plays a crucial role in tumorigenesis and tumor progression by direct targeting of E2F3 in renal cell carcinoma [31]. The gene discussed is E2F3; the disease is hereditary clear cell renal cell carcinoma.